Plerixafor
RxNorm 733003
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 733003 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Plerixafor.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Plerixafor
(Atom ID: 12252352)
PTPrescribable
Designated preferred name (PT):
Plerixafor
(Atom ID: 2985853)
FNPrescribable
Full form of descriptor (FN):
Plerixafor (substance)
(Atom ID: 2985855)
PTPrescribable
Designated preferred name (PT):
Plerixafor-containing product
(Atom ID: 10809332)
FNPrescribable
Full form of descriptor (FN):
Product containing plerixafor (medicinal product)
(Atom ID: 9731275)
Patient Education
Plerixafor Injection
Plerixafor injection is used along with a granulocyte-colony stimulating factor (G-CSF) medication such as filgrastim (Neupogen) or pegfilgrastim (Neulasta) to prepare the blood for an autologous stem cell transplant (procedure in which certain blood cells are removed from the body and then returned to the body after chemotherapy and/or radiation) in patients with non-Hodgkin's lymphoma (NHL; cancer that begins in a type of white blood cells that normally fights infection) or multiple myeloma (a type of cancer of the bone marrow). Plerixafor injection is in a class of medications called hematopoeitic stem cell mobilizers. It works by causing certain blood cells to move from the bone marrow to the blood so that they can be removed for transplant.
[Learn More]
* Please review the disclaimer below.